From the American Academy of Ophthalmology

This retrospective review evaluated the efficacy of an intravitreal dexamethasone implant in 18 patients with retinal vein occlusion who previously received multiple bevacizumab injections. Patients responded with an average reduction in central foveal thickness of 146.8 ± 33.65 μm. Visual acuity also improved 0.26 ± 0.07 (logarithm of minimal angle of resolution). IOP increased by an average of 3.33 ± 0.66 mmHg, which was managed with topical treatment. Retina, June 2013